Atlas Trials

Symphony IL-6 Cutoff Establishment Study for Patients at Risk of Severe Sepsis Due to COVID-19

Clinical trial NCT05060250 · UNKNOWN

Trial details

NCT number
NCT05060250
Sponsor
Bluejay Diagnostics, Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Severe Sepsis
Start date
2021-08-31
Primary completion
2024-11-30
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.